Glitazone Treatment and Incidence of Parkinson's Disease among People with Diabetes: A Retrospective Cohort Study.

<h4>Background</h4>Recent in vitro and animal experiments suggest that peroxisome proliferation-activated receptor gamma (PPARɣ) agonist medications, such as antidiabetic glitazone (GTZ) drugs, are neuroprotective in models of Parkinson's disease (PD). These findings have not been t...

Full description

Saved in:
Bibliographic Details
Main Authors: Ruth Brauer, Krishnan Bhaskaran, Nishi Chaturvedi, David T Dexter, Liam Smeeth, Ian Douglas
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2015-07-01
Series:PLoS Medicine
Online Access:https://doi.org/10.1371/journal.pmed.1001854
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items